Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000644898 | SCV000766616 | pathogenic | Hereditary spastic paraplegia 4 | 2021-04-15 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with hereditary spastic paraplegia (PMID: 31157359, Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 536446). This sequence change replaces isoleucine with lysine at codon 592 of the SPAST protein (p.Ile592Lys). The isoleucine residue is highly conserved and there is a moderate physicochemical difference between isoleucine and lysine. This variant is not present in population databases (ExAC no frequency). |
Mayo Clinic Laboratories, |
RCV001508983 | SCV001715444 | likely pathogenic | not provided | 2020-02-07 | criteria provided, single submitter | clinical testing | PM1, PM2, PM6, PP3 |
Gene |
RCV001508983 | SCV001819742 | pathogenic | not provided | 2019-06-20 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31157359) |
Developmental and Behavioral Pediatrics, |
RCV000644898 | SCV002576304 | likely pathogenic | Hereditary spastic paraplegia 4 | no assertion criteria provided | provider interpretation |